Cargando…

Risk Factors for Mortality and Antimicrobial Regimens in Pediatric Intensive Care Unit Patients with Carbapenem-Resistant Enterobacteriaceae Infections: A Six-Year Retrospective Study

PURPOSE: Limited data are available on the characteristics, risk factors, and antimicrobial treatment of critically ill pediatric patients with carbapenem-resistant Enterobacteriaceae (CRE) infections. This study was to identify the risk factors for 30-day mortality in pediatric intensive care unit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peng, Mai, Yumiao, Yuan, Wenhua, Xie, Lei, Ma, Wei, Liu, Jian, Xu, Lu, Yang, Jing, Wang, Peile, Wang, Huaili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758918/ https://www.ncbi.nlm.nih.gov/pubmed/36536864 http://dx.doi.org/10.2147/IDR.S394283

Ejemplares similares

Mortality-Related Risk Factors and Novel Antimicrobial Regimens for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review
por: Hu, Qin, et al.
Publicado: (2022)

Prevalence of Carbapenem-Resistant Enterobacteriaceae in Western Saudi Arabia and Increasing Trends in the Antimicrobial Resistance of Enterobacteriaceae
por: Taha, Rbab, et al.
Publicado: (2023)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae
por: Chen, Chi-Chung, et al.
Publicado: (2019)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection
por: So-ngern, Apichart, et al.
Publicado: (2023)

Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999–2012
por: Logan, Latania K., et al.
Publicado: (2015)

Risk factor for mortality associated with carbapenem-resistant Enterobacteriacea infections
por: Carrilho, Cláudia MDM, et al.
Publicado: (2013)

Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department
por: Salomão, Matias Chiarastelli, et al.
Publicado: (2020)

Evaluation of phenotypic tests to detect carbapenem-resistant Enterobacteriaceae in colonized patients hospitalized in intensive care units
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2015)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Fosfomycin Dosing Regimens based on Monte Carlo Simulation for Treated Carbapenem-Resistant Enterobacteriaceae Infection
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2020)

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis()
por: Abboud, Cely Saad, et al.
Publicado: (2017)

A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States
por: Livorsi, Daniel J., et al.
Publicado: (2018)

1250. Prevalence and Risk Factors for Acquiring Carbapenem-Resistant Enterobacteriaceae in an Intensive Care Unit at a Tertiary Hospital
por: Kang, Jin Suk, et al.
Publicado: (2018)

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae
por: Li, Xiaopeng, et al.
Publicado: (2017)

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
por: Chiotos, Kathleen, et al.
Publicado: (2018)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
por: Petty, Lindsay A, et al.
Publicado: (2018)

Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational Study
por: Cancelli, F., et al.
Publicado: (2018)

Investigation and Analysis of the Colonization and Prevalence of Carbapenem-Resistant Enterobacteriaceae in Pediatric Liver Transplant Recipients
por: Sun, Yan, et al.
Publicado: (2021)

P075: Emergence of carbapenem-resistant enterobacteriaceae in surgical and intensive care units of a hospital with low usage of carbapenem in Kano, North West Nigeria
por: Yusuf, I, et al.
Publicado: (2013)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis
por: Zhou, Ruyin, et al.
Publicado: (2021)

132. Carbapenem-resistant Enterobacteriaceae colonization in a Neonatal Intensive Care Unit in Bogotá, Colombia: Characterization and clinical outcomes
por: Londono-Ruiz, Juan Pablo, et al.
Publicado: (2022)

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

417. Factors associated with 30-day Mortality in Carbapenems-resistant Enterobacteriaceae Infections
por: Osaithai, Naphol, et al.
Publicado: (2022)

Predictors of Mortality and Drug Resistance Among Carbapenem-Resistant Enterobacteriaceae-Infected Pancreatic Necrosis Patients
por: Wu, Di, et al.
Publicado: (2021)

Admission screening and cohort care decrease carbapenem resistant enterobacteriaceae in Vietnamese pediatric ICU’s
por: Garpvall, K., et al.
Publicado: (2021)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
por: Korach-Rechtman, Hila, et al.
Publicado: (2020)

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae
por: Armin, Shahnaz, et al.
Publicado: (2023)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae
por: Tuon, Felipe F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fgjnf24q20eu1hrl7qohvaimsh